Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDLI

This article was originally published in The Tan Sheet

Executive Summary

Former USP Exec VP/CEO Jerome Halperin named president effective July 1, replacing John Villforth, who is stepping down after more than 10 years with the Food & Drug Law Institute. Halperin, FDLI's treasurer and a board member since 1991, recently received the 2001 American Pharmaceutical Association Remington Honor Medal (1"The Tan Sheet" March 26, In Brief)

You may also be interested in...



Halperin honored

Former USP CEO/Exec VP Jerome Halperin receives American Pharmaceutical Association Remington Honor Medal March 18. Halperin was recognized for his more than 40 year pharmacy-related tenure in practice, government, uniformed services, industry and USP. Halperin served as highest ranking career pharmacy officer in FDA and was third pharmacist to achieve Rear Admiral rank in Public Health Service

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

LL111799

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel